Polypeptide Expression in Breast Cancer
Author Information
Author(s): B Franzen, S Linder, AA Alaiya, E Eriksson, K Uruy, T Hirano, K Okuzawa, G Auer
Primary Institution: Karolinska Institute and Hospital
Hypothesis
The study investigates the expression levels of various polypeptides in benign and malignant breast lesions.
Conclusion
The study found that malignant breast carcinomas exhibit decreased levels of cytokeratin polypeptides compared to benign fibroadenomas.
Supporting Evidence
- PCNA levels were 4.3-fold higher in highly malignant tumours than in non-malignant cells.
- Cytokeratin levels were significantly lower in carcinomas than in fibroadenomas.
- Decreases in tropomyosin 2 and 3 were statistically significant in carcinomas.
Takeaway
The study looked at proteins in breast cancer and found that cancer cells have less of certain proteins compared to non-cancer cells.
Methodology
Two-dimensional gel electrophoresis (2-DE) was used to analyze polypeptide expression in breast carcinoma cells and fibroadenoma tissue.
Limitations
The study excluded cases with unclear classification and faced challenges with protein contamination from other cell types.
Participant Demographics
The study included 23 breast lesions, with 6 non-malignant and 17 malignant cases.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website